Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills

Founder and CEO of Nvidia Corp (NASDAQ:NVDA), Jensen Huang, announced on Wednesday that the company has inked two new large partnerships to advance its work in healthcare.

The first is with European-based weight loss drug maker Novo Nordisk A/S (NYSE:NVO) to accelerate drug discovery and development efforts by leveraging an existing partnership with the Danish Centre for AI Innovation's (DCAI) Gefion AI supercomputer.

Also Read: Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable

The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development and to apply advanced simulation and physical AI technologies.

Novo Nordisk will use NVIDIA BioNeMo for generative AI-powered drug discovery, NVIDIA NIM, and NVIDIA NeMo microservices ...